Back to search

Article

Ethnic Differences on Long Term Outcomes of Polypoidal Choroidal Vasculopathy after Predominantly Bevacizumab Monotherapy.

2022-02-09

Abstract excerpt

<h4>Background: </h4> A 3-year single-centre, retrospective, comparative, non-randomized cohort study to describe the long-term outcomes of treatment-naïve, Caucasian and non-Caucasian eyes with polypoidal choroidal vasculopathy (PCV) after treatment with predominantly Bevacizumab monotherapy or in combination with rescue photodynamic therapy (PDT). <h4>Methods:</h4> Demographics, visual outcomes, optical coherenc...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
1657f3b1-07a6-57e1-baf6-6850b22390f0
DOI
10.21203/rs.3.rs-1317439/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Ethnic Differences on Long Term Outcomes of Polypoidal Choroidal Vasculopathy after Predominantly Bevacizumab Monotherapy.DOI 10.21203/rs.3.rs-1317439/v1
Pachychoroid-phenotype effects on 5-year visual outcomes of anti-VEGF monotherapy in polypoidal choroidal vasculopathy.Semantic proximity
Polypoidal choroidal vasculopathy and neovascular age-related macular degeneration: same or different disease?Semantic proximity
Two-year visual outcome of polypoidal choroidal vasculopathy treated with photodynamic therapy combined with intravitreal injections of ranibizumab.Semantic proximity
Comparison of two-year outcomes after photodynamic therapy with ranibizumab or aflibercept for polypoidal choroidal vasculopathy.Semantic proximity
Differences between young and elderly polypoidal choroidal vasculopathy patients with and without pachychoroid phenotypes.Semantic proximity
Two-year visual outcome of ranibizumab in typical neovascular age-related macular degeneration and polypoidal choroidal vasculopathy.Semantic proximity
Polypoidal Choroidal Vasculopathy and Pachychoroid Neovasculopathy representing Different Manifestations of the Same Spectrum in the Same Patient: A Case ReportSemantic proximity
T and genetic variations between Asian and Caucasian polypoidal choroidal vasculopathy.Semantic proximity
The Moorfields AMD Database Report 2 - Fellow Eye Involvement with Neovascular Age-related Macular DegenerationSemantic proximity
Genetic Variants Affecting Anti-VEGF Drug Response in Polypoidal Choroidal Vasculopathy Patients: A Systematic Review and Meta-Analysis.Semantic proximity
The association of polypoidal choroidal vasculopathy clinical phenotypes with previously reported genetic markers.Semantic proximity
Chorioretinal Atrophy after Voretigene Neparvovec Therapy in <italic>RPE65</italic> Mutation-Associated Inherited Retinal Disease: Longitudinal Characterization in Multimodal Imaging.Semantic proximity
Select a neighboring publication to make it the new centre.